Loading provider…
Loading provider…
Neurological Surgery Physician in Rochester, MN
NPI: 1083873442Primary Practice Location
MAYO CLINIC HOSPITAL ROCHESTER
201 W Center St, Rochester, MN
Primary Employer
Mayo Clinic - Mayo Building and Gonda Building
mayoclinic.org
HQ Phone
Get M.D. Ian's Phone Numberphone_androidMobile
Get M.D. Ian's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMN State Medical License
CA State Medical License
2002
MN State Medical License
2008 - 2026

American Board of Neurological Surgery
Neurological Surgery
University of Alberta
Medical School
Until 1993
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99203New patient outpatient visit, total time 30-44 minutes | 42 | 42 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 33 | 39 |
| 3 | 61781Computer-assisted procedure inside the brain | 23 | 24 |
| 4 | 61510Removal of brain tumor | 21 | 22 |
| 5 | 69990Use of operating microscope | 20 | 21 |
Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition.
Authors: James Kirkland, Terence Burns, Lucas Carlstrom
Journal: Mol Cancer Res
Authors: Carlos Perez Vega, Roman Kowalchuk, Sujay Vora, Daniel Trifiletti, David Crompton, Bradley Erickson
Journal: J Neurooncol
Publication Date: 2022-07-19
Authors: Ryan Naylor, Lorenzo Rinaldo, Desmond Brown, Hannah Gilder
Journal: J Neurosurg
Publication Date: 2019-01-04
Lead Sponsor: Mayo Clinic
Intervention / Treatment: DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Pembrolizumab, RADIATION: External Beam Radiation Therapy, PROCEDURE: Therapeutic Conventional Surgery, RADIATION: Radiation Therapy
Lead Sponsor: Mayo Clinic
Intervention / Treatment: DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
Lead Sponsor: Mayo Clinic
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine